| Product NDC: | 66336-336 | 
| Proprietary Name: | Cetirizine Hydrochloride | 
| Non Proprietary Name: | Cetirizine Hydrochloride | 
| Active Ingredient(s): | 10 mg/1 & nbsp; Cetirizine Hydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 66336-336 | 
| Labeler Name: | Dispensing Solutions, Inc. | 
| Product Type: | HUMAN OTC DRUG | 
| FDA Application Number: | ANDA077946 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20071227 | 
| Package NDC: | 66336-336-14 | 
| Package Description: | 14 TABLET in 1 BOTTLE (66336-336-14) | 
| NDC Code | 66336-336-14 | 
| Proprietary Name | Cetirizine Hydrochloride | 
| Package Description | 14 TABLET in 1 BOTTLE (66336-336-14) | 
| Product NDC | 66336-336 | 
| Product Type Name | HUMAN OTC DRUG | 
| Non Proprietary Name | Cetirizine Hydrochloride | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20071227 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Dispensing Solutions, Inc. | 
| Substance Name | CETIRIZINE HYDROCHLORIDE | 
| Strength Number | 10 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes |